Evaluation of 18F-FDG PET/CT and CT/MRI with Histopathologic Correlation in Patients Undergoing Salvage Surgery for Head and Neck Squamous Cell Carcinoma

[1]  D. Heron,et al.  Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  Johan Bussink,et al.  PET-CT for response assessment and treatment adaptation in head and neck cancer. , 2010, The Lancet. Oncology.

[3]  E. Vokes,et al.  Neck response to chemoradiotherapy: complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancer. , 2009, Archives of otolaryngology--head & neck surgery.

[4]  B.J. Boyce,et al.  Revisiting the role of positron‐emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer , 2009, The Laryngoscope.

[5]  J. Buatti,et al.  Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-a long-term outcome report. , 2009, International journal of radiation oncology, biology, physics.

[6]  J. Hatazawa,et al.  The role of CT and 18F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy , 2009, Acta oto-laryngologica.

[7]  C. McConkey,et al.  A systematic review and meta‐analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy , 2008, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[8]  N. Tamaki,et al.  Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer , 2008, Annals of nuclear medicine.

[9]  S. Larson,et al.  Clinical Utility of 18F-FDG PET/CT in Assessing the Neck After Concurrent Chemoradiotherapy for Locoregional Advanced Head and Neck Cancer , 2008, Journal of Nuclear Medicine.

[10]  Jeong Hyun Lee,et al.  Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. , 2007, Oral oncology.

[11]  L. Rybicki,et al.  Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy. , 2007, Archives of otolaryngology--head & neck surgery.

[12]  D. Heron,et al.  Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. , 2006, International journal of radiation oncology, biology, physics.

[13]  J. Buatti,et al.  The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment. , 2005, International journal of radiation oncology, biology, physics.

[14]  Ho-Fai Wong,et al.  18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  C. Snyderman,et al.  Combined PET-CT in the head and neck: part 2. Diagnostic uses and pitfalls of oncologic imaging. , 2005, Radiographics : a review publication of the Radiological Society of North America, Inc.

[16]  L. Weih,et al.  Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer , 2005, Head & neck.

[17]  P. Levine,et al.  Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. , 2002, Archives of otolaryngology--head & neck surgery.

[18]  S. Stoeckli,et al.  Is there a role for positron emission tomography with 18F‐fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma , 2002, Head & neck.

[19]  R. D'Agostino,et al.  Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer , 2001, Head & neck.

[20]  H. Curtin,et al.  Imaging-based nodal classification for evaluation of neck metastatic adenopathy. , 2000, AJR. American journal of roentgenology.

[21]  E. Vokes,et al.  Expanding Role of the Medical Oncologist in the Management of Head and Neck Cancer , 2008, CA: a cancer journal for clinicians.

[22]  H. Mcguff,et al.  The role of computed tomographic scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. , 2004, Archives of otolaryngology--head & neck surgery.

[23]  N. Sadato,et al.  Prospective Comparison of 18 F-FDG PET with Conventional Imaging Modalities ( MRI , CT , and 67 Ga Scintigraphy ) in Assessment of Combined Intraarterial Chemotherapy and Radiotherapy for Head and Neck Carcinoma , 2003 .

[24]  A. Garden,et al.  Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. , 1996, Head & neck.